Under Therapeutic Pressure: ELCC Session Highlights How Tumor Switching is Reshaping the Treatment Landscape

… to develop complex resistance. Under therapeutic pressure, tumor evolution—or “switching”—can manifest in various ways, … transformation data and complex interpretation. “ctDNA is helpful if we witness systemic progression, …

Using Early ctDNA, Study Findings Inform Prognostic Model

… PhD, at the 2025 World Conference on Lung Cancer, evaluated circulating tumor DNA (ctDNA) as a predictive biomarker for consolidation …